Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Heine

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Immunology Letters|May 11, 2011
TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases--a current viewHolger Heine
Frontiers in Immunology|February 15, 2021
Corrigendum: Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory PathwaysAlla Zamyatina, Holger Heine
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A MimeticsHolger Heine, Alla Zamyatina
Frontiers in Immunology|December 17, 2020
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory PathwaysAlla Zamyatina, Holger Heine
International Archives of Allergy and Immunology|March 28, 2003
Toll-like receptors and their function in innate and adaptive immunityHolger Heine, Egil Lien
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 27, 2016
Allergy protection by cowshed bacteria - recent findings and future prospectsMarion Kauth, Holger Heine
Chemical Immunology and Allergy|June 25, 2005
Recognition of bacterial products by toll-like receptorsHolger Heine, Artur J Ulmer
Plos One|November 28, 2012
Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cellsKimberley Kallsen, Ellen Andresen, Holger Heine
Allergy|November 27, 2018
RNA is taking its Toll: Impact of RNA-specific Toll-like receptors on health and diseaseTim Vierbuchen, Karina Stein, Holger Heine
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 19, 2022
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and AdjuvantsSebastian Strobl, Karin Hofbauer, Holger Heine, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Immunology Letters|May 11, 2011
TLRs, NLRs and RLRs: innate sensors and their impact on allergic diseases--a current viewHolger Heine
Frontiers in Immunology|February 15, 2021
Corrigendum: Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory PathwaysAlla Zamyatina, Holger Heine
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A MimeticsHolger Heine, Alla Zamyatina
Frontiers in Immunology|December 17, 2020
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory PathwaysAlla Zamyatina, Holger Heine
International Archives of Allergy and Immunology|March 28, 2003
Toll-like receptors and their function in innate and adaptive immunityHolger Heine, Egil Lien
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 27, 2016
Allergy protection by cowshed bacteria - recent findings and future prospectsMarion Kauth, Holger Heine
Chemical Immunology and Allergy|June 25, 2005
Recognition of bacterial products by toll-like receptorsHolger Heine, Artur J Ulmer
Plos One|November 28, 2012
Histone deacetylase (HDAC) 1 controls the expression of beta defensin 1 in human lung epithelial cellsKimberley Kallsen, Ellen Andresen, Holger Heine
Allergy|November 27, 2018
RNA is taking its Toll: Impact of RNA-specific Toll-like receptors on health and diseaseTim Vierbuchen, Karina Stein, Holger Heine
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 19, 2022
Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and AdjuvantsSebastian Strobl, Karin Hofbauer, Holger Heine, et al.
Pageof 10